Role of NAC for Treatment-Resistant OCD
ROLE OF NAC FOR TREATMENT-RESISTANT OCD
This is a short 5-minute video from Psychiatry Education Forum’s 1st CME Conference. Here I will discuss the role of NAC (N-Acetyl Cysteine) in the management of treatment-resistant OCD:
Psychiatry Education Forum’s first CME online conference is dedicated to the essential and must-know clinical facts in psychiatry. This conference will offer a maximum of 10 AMA PRA Category 1 Credits™ for topics clinically relevant to your daily clinical practice.
- Online conference: finish this conference at your own pace, and at any time with no need to spend money on travel-related expenses.
- Peer-Reviewed: each presentation is reviewed by independent peer-reviewers (read our peer-reviewers details below).
- No Disclosures: No pharmaceutical or non-pharmaceutical sponsors. All lectures are based on clinical data from literature with no influence from sponsors.
- Conference Booklet: PDF version of reading material for each lecture will also be provided.
BLACK FRIDAY WEEKEND SALE:
Conference is Available on 30% Discount for 72 hours only:
If the discounted rate applies to you: Email us at
HSingh@PsychiatryEducationForum.com
CONFERENCE TABLE OF CONTENT:
10 AMA PRA Category 1 Credits™:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and the Psychiatry Education Forum LLC. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.
PeerPoint Medical Education Institute designates the enduring material format for this educational activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
